| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.26 | 7e-13 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-12 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-12 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-12 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-11 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-10 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-10 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |